eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Brucellosis

Author: Nicholas John Bennett, MBBCh, PhD, Staff Physician, Department of Pediatrics, State University of New York Upstate Medical University
Coauthor(s): Joseph Domachowske, MD, Associate Professor, Department of Pediatrics, Division of Infectious Diseases, State University of New York-Upstate Medical University; Walid Abuhammour, MD, FAAP, Associate Professor of Pediatrics, Michigan State University; Director of Pediatric Infectious Disease, Department of Pediatrics, Hurley Medical Center; Khaled Nashar, MD, Instructor of Clinical Internal Medicine, Section of Hospitalist Medicine, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh Medical Center
Contributor Information and Disclosures

Updated: Jan 25, 2008

Introduction

Background

The first clinical case compatible with brucellosis was credited to JA Maston, an assistant surgeon in the Royal Army Medical Corps. Brucellosis in an alphaproteobacteria that was discovered in 1887 by David Bruce, an English doctor working with British soldiers in Malta, by microscopic examination of a spleen from a fatal case.

Brucellosis is primarily a zoonotic infectious disease found in both domestic and wild animals. Humans are accidental hosts, but brucellosis continues to be a major public health concern worldwide and is the most common zoonotic infection. Brucellosis has been known by various names, including Mediterranean fever, Malta fever, gastric remittent fever, and undulant fever.

Brucellosis can be acquired via exposure to infected animals or infected food. The primary means of prevention is the pasteurization of dairy products, but slaughter campaigns of infected cattle have also been used to control the infection at its source in some countries.

Pathophysiology

Brucella species are facultative intracellular pathogens that are capable of surviving and replicating within phagocytic cells of the host. Shortly after gaining entry to the body, brucellae are ingested by polymorphonuclear leukocytes (PMLs), which are attracted to the site of inoculation. The principal virulence factor is cell wall lipopolysaccharide (LPS). Normal serum factors, including complement, are involved in opsonization of the organisms to allow phagocytosis, but PMLs have limited ability to kill bacteria within phagocytes. A copper-zinc superoxide dismutase, o- polysaccharide, and nucleotidelike substances are among the factors that protect brucellae from being killed by PMLs.

Brucellae that are not killed by PMLs are ingested by macrophages, where they become localized within organs of the reticuloendothelial system (ie, liver, spleen, bone marrow) and multiply in macrophages and monocytes. However, any organ system can be involved in brucellosis (ie, CNS, heart, joints, genitourinary system, pulmonary system, and skin), and localization of the process may cause focal symptoms or findings.

Shortly after infection, humoral antibodies directed against LPS and other cell wall antigens are produced. However, development of cell-mediated immunity is the principle mechanism of recovery. The host response to infection with Brucella abortus is characterized by the development of tissue granulomas indistinguishable from those of sarcoidosis. In contrast, infection with the more virulent species (Brucella melitensis, Brucella suis) more commonly results in visceral microabscesses.

Frequency

United States

Brucellosis is still a reportable disease in the United States, although the Centers for Disease Control and Prevention (CDC) has received reports of only 100-200 cases annually (a rate of 0.4 per one million population) in the last several years. Texas has the highest incidence of cases (1.38 per one million population). Nationally, the infection is due to 2 main sources: importation of disease (from infected food products or international travel) and cross-border spread1 (mostly B melitensis) from Mexico into neighboring states (mostly affecting Hispanics).

International

The geographic distribution of brucellosis is limited by effective public and animal health programs, and prevalence of the disease widely varies from country to country.2 Brucellosis is still endemic in the Mediterranean countries, the Arabian Peninsula, Western Asia, Eastern Europe, and parts of Africa and Latin America. Control campaigns have effectively removed it from countries like the United Kingdom and Ireland. Early vaccination attempts were problematic; the vaccine controlled symptoms of the disease but did not actually prevent infection.

A clear (although nonlinear) association between gross domestic product (GDP) and rates of brucellosis is evident according to European Union (EU) data. No countries with a GDP above 90% of the mean had an incidence above 10 annual cases per million population.

In very resource-poor countries (such as some African countries) in which brucellosis is endemic, control through animal slaughter is a poor option because of the fragile nature of the food supply.

Mortality/Morbidity

Duration of symptoms for more than 30 days before diagnosis is the major risk factor for developing focal disease. Mortality is low (<2%) and is most frequently found in those with endocarditis due to brucellosis.

  • The most common focal complications are as follows:
    • Osteoarticular complications - Especially, sacroiliitis (20-30% - but rarer in children)
    • Genitourinary tract complications - Especially, epididymoorchitis in males (2-49%)
    • Neurobrucellosis3 - Meningitis4 (1-2%) and, less commonly, papilledema, optic neuropathy, radiculopathy, stroke, and intracranial hemorrhage
    • Endocarditis (1%) - Responsible for most mortality associated with the disease
    • Hepatic abscess (1%)
  • Other less common complications include the following:
    • Splenic abscess
    • Thyroid abscess
    • Epidural abscess
    • Pneumonitis
    • Pleural empyema
    • Uveitis
    • Aneurysm of the aorta
    • Aneurysm of the cerebral vessels
    • Peritonitis

Race

No racial predilection is known (however, see United States for information about cross-border cases).

Sex

Food-borne brucellosis is not limited according to age or sex and is found in women and men in equal numbers.

Age

Farmers, ranchers, veterinarians, and meat inspectors have the highest risk; however, people of all ages are susceptible. Childhood brucellosis is more common in countries where B melitensis is the prevalent species; in the United States, only about 10% of cases occur in people younger than 19 years.

Clinical

History

In children, brucellosis is frequently a mild self-limiting illness and is less chronic than in adults. A key element in the history is exposure to an infected animal or food. Symptoms are nonspecific, usually occurring within 2-4 weeks of inoculation.

  • Symptoms include weakness, excessive sweating, lethargy, anorexia, weight loss, arthralgia, myalgia, abdominal pain, and headache.5
  • Symptoms in young children include refusal to eat, lassitude, refusal to bear weight, and failure to thrive.
  • Brucellosis can present as a fever of unknown origin,6 and the fever may undulate, repeatedly coming and going (hence, the term "undulant fever").
  • In the chronic form, with longer than 1 year of illness (undiagnosed and untreated brucellosis), an afebrile pattern is typical, with a history of myalgia, fatigue, depression, and arthralgias (chronic fatigue syndrome is the most important disease in the differential diagnosis). The chronic form is primarily caused by B melitensis and usually affects adults older than 30 years. The chronic form is rare in children.

Physical

Physical abnormalities can be minimal. Fever and minimal lymphadenopathy are the most common physical findings. Occasionally, hepatosplenomegaly may be present. Disease is infrequently localized; physical findings are predominately related to a single organ.

  • Physical examination reveals hot swollen tender joints, with limited movement in patients with arthritis (most commonly knees, ankles, and hips).
  • A point of tenderness and limited movement is present in patients with osteomyelitis.
  • Sacroiliitis is rare in children.
  • Nuchal rigidity, Kerning sign, and Brudzinski sign are seen if meningitis is the focal point.
  • Papilledema, cranial nerve palsy, and focal neurologic deficits may be present in patients with increased intracranial pressure or brain abscess.
  • Generalized tenderness, rebound tenderness, and sluggish or absent bowel sounds can be expected in patients with peritonitis.
  • A tender swollen scrotum with erythema is present in patients with epididymoorchitis.
  • A new or changing murmur may be detected in patients with infective endocarditis.
  • A pericardial rub is present in patients with pericarditis.

Causes

Brucella species are small, fastidious, non–spore-forming, gram-negative coccobacilli. They lack flagella, endospores, capsules, and naturally occurring plasmids. Their metabolism is oxidative, and all strains are aerobic, although some species require carbon dioxide for primary isolation.
 
Brucellae have catalase activity, but oxidase activity varies. Most strains reduce nitrate to nitrite. Hydrogen sulfide production and urase activity also vary. The bacteria can be grown on various laboratory media, including serum dextrose, blood, and chocolate agar. Four species are pathogenic to humans: B abortus, B melitensis, B suis, and Brucella canis.

Table 1. Animal Hosts for Brucella Species

Open table in new window

Table
Nomina SpeciesBiovarsPreferred Host
B abortus1-6, 9Cattle
B melitensis1-3Goats, sheep
B suis1-3Swine
4Reindeer
5Rodents
B canisNoneDogs
Nomina SpeciesBiovarsPreferred Host
B abortus1-6, 9Cattle
B melitensis1-3Goats, sheep
B suis1-3Swine
4Reindeer
5Rodents
B canisNoneDogs

More on Brucellosis

Overview: Brucellosis
Differential Diagnoses & Workup: Brucellosis
Treatment & Medication: Brucellosis
Follow-up: Brucellosis
References

References

  1. Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. J Infect Dis. Nov 2000;182(5):1503-10. [Medline].

  2. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. Feb 2006;6(2):91-9. [Medline][Full Text].

  3. Shakir RA. Neurobrucellosis. Postgrad Med J. Dec 1986;62(734):1077-9. [Medline].

  4. Tena D, Gonzalez-Praetorius A, Lopez-Alonso A, et al. Acute meningitis due to Brucella spp. Eur J Pediatr. May 12 2006;[Medline].

  5. al-Eissa YA, Kambal AM, al-Nasser MN, et al. Childhood brucellosis: a study of 102 cases. Pediatr Infect Dis J. Feb 1990;9(2):74-9. [Medline].

  6. Sharda DC, Lubani M. A study of brucellosis in childhood. Clin Pediatr (Phila). Oct 1986;25(10):492-5. [Medline].

  7. Mitka S, Anetakis C, Souliou E, Diza E, Kansouzidou A. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol. Apr 2007;45(4):1211-8. [Medline].

  8. Young EJ, Tarry A, Genta RM, et al. Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis. Oct 2000;31(4):904-9. [Medline].

  9. Lubani MM, Dudin KI, Sharda DC, et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. Feb 1989;8(2):75-8. [Medline].

  10. Roushan MR, Mohraz M, Janmohammadi N, Hajiahmadi M. Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis. Pediatr Infect Dis J. Jun 2006;25(6):544-5. [Medline].

  11. Corbel MJ. Vaccines against bacterial zoonoses. J Med Microbiol. Apr 1997;46(4):267-9. [Medline].

  12. Lubani M, Sharda D, Helin I. Brucella arthritis in children. Infection. Sep-Oct 1986;14(5):233-6. [Medline].

  13. al-Eissa YA, al-Mofada SM. Congenital brucellosis. Pediatr Infect Dis J. Aug 1992;11(8):667-71. [Medline].

  14. Committee on Infectious Diseases. Brucellosis. In: Red Book. 27th Ed. 2006:235-237.

  15. Schultze GE, Jacobs RF. Brucella. In: Behrman RE, Kliegman R, Jenson HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia, Pa: WB Saunders; 2000:868-9.

  16. Trifiletti RR, Restivo DA, Pavone P, et al. Diabetes insipidus in neurobrucellosis. Clin Neurol Neurosurg. Sep 2000;102(3):163-5. [Medline].

  17. Young EJ. An overview of human brucellosis. Clin Infect Dis. Aug 1995;21(2):283-9; quiz 290. [Medline].

Further Reading

Keywords

brucellosis, Brucella abortus, Brucella melitensis, Brucella suis, Brucella canis, Brucella infection, zoonosis, Mediterranean fever, Malta fever, gastric remittent fever, undulant fever, sarcoidosis, endocarditis, sacroiliitis, epididymoorchitis, meningitis, papilledema, optic neuropathy, radiculopathy, stroke, intracranial hemorrhage, neurobrucellosis, hepatic abscess, splenic abscess, thyroid abscess, epidural abscess, pneumonitis, pleural empyema, uveitis, peritonitis, food-borne brucellosis, failure to thrive, chronic fatigue syndrome, hepatosplenomegaly, lymphadenopathy, arthritis, osteomyelitis

Contributor Information and Disclosures

Author

Nicholas John Bennett, MBBCh, PhD, Staff Physician, Department of Pediatrics, State University of New York Upstate Medical University
Nicholas John Bennett, MBBCh, PhD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Coauthor(s)

Joseph Domachowske, MD, Associate Professor, Department of Pediatrics, Division of Infectious Diseases, State University of New York-Upstate Medical University
Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Walid Abuhammour, MD, FAAP, Associate Professor of Pediatrics, Michigan State University; Director of Pediatric Infectious Disease, Department of Pediatrics, Hurley Medical Center
Walid Abuhammour, MD, FAAP is a member of the following medical societies: American Medical Association and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

Khaled Nashar, MD, Instructor of Clinical Internal Medicine, Section of Hospitalist Medicine, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh Medical Center
Khaled Nashar, MD is a member of the following medical societies: American College of Physicians, American Medical Association, and American Society of Hypertension
Disclosure: Nothing to disclose.

Medical Editor

Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine
Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Mark R Schleiss, MD, American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota School of Medicine
Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Professor and Vice Chairman, Department of Pediatrics, Head, Division of Infectious Diseases, Louisiana State University Health Sciences Center
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.